Evidence map›Paper›PMID 36799434›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Effect of Coronavirus Disease 2019 Lockdowns on Identification of Advanced Human Immunodeficiency Virus Disease in Outpatient Clinics in Uganda.

Elizabeth Nalintya, Preethiya Sekar, Paul Kavuma, Joanita Kigozi, Martin Ssuna, Paul Kirumira, Rose Naluyima, Teopista Namuli, Fred Turya Musa, Caleb P Skipper and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Elizabeth NalintyaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Preethiya SekarDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA.
Paul KavumaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Joanita KigoziInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Martin SsunaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Paul KirumiraInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Rose NaluyimaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Teopista NamuliInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Fred Turya MusaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Caleb P SkipperDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA.
Kathy Huppler HullsiekDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA.
Jayne EllisInfectious Diseases Institute, Makerere University, Kampala, Uganda.
David R BoulwareDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA.
David B MeyaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Radha RajasinghamDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA.ORCID 0000-0001-5531-0231

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
Institutional Career Development CoreKL2TR002492 · NCATS · UNIVERSITY OF MINNESOTA · PI INGBAR, DAVID H · 2018 to 2022
$6.3M
Operational Research for Cryptococcal Antigen Screening (ORCAS) of HIV PatientsU01AI125003 · NIAID · UNIVERSITY OF MINNESOTA · PI BOULWARE, DAVID R, MEYA, DAVID BISAGAYA · 2016 to 2020
$3.4M
Evaluation of CRAG screening with enhanced antifungal therapy for asymptomatic CRAG-positive personsK23AI138851 · NIAID · UNIVERSITY OF MINNESOTA · PI RAJASINGHAM, RADHA · 2018 to 2022
$954k
FIC NIH HHS D43 TW009345NCATS NIH HHSNCATS NIH HHS KL2 TR002492NCATS NIH HHS UL1 TR002494NIAID NIH HHS K23 AI138851NIAID NIH HHS U01 AI125003Wellcome TrustWellcome Trust 203905/Z/16/Z
6 · The paper itself

Abstract

Using data from 67 Ugandan human immunodeficiency virus (HIV) clinics (July 2019-January 2022), we report a 40% (1005/1662) reduction in the number of people with HIV presenting to care after August 2021 compared to prepandemic levels, with a greater proportion presenting with advanced HIV disease (20% vs 16% in the pre-coronavirus disease 2019 period).

Indexed as

COVID-19HIV InfectionsAmbulatory Care FacilitiesCommunicable Disease ControlHIVHumansUgandaadvanced HIV diseaseCOVID-19opportunistic infections

Identifiers

PMID36799434
PMCPMC10249983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.